Oil prices hold sharp losses with focus on secondary India tariffs
Haleon plc (LSE/NYSE:HLN) has announced an update on its total voting rights and capital. As of May 31, 2025, the company has issued a total of 9,005,330,185 ordinary shares, each with a nominal value of £0.01. Of these, 4,080,205 shares are held in treasury, leaving 9,001,249,980 ordinary shares with voting rights.
Shareholders and others with notification obligations are advised to use the 9,001,249,980 figure as the denominator for calculations under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. This information is based on a press release statement issued by the company.
Haleon, a global leader in consumer health, operates in categories such as oral health, vitamins, minerals and supplements, pain relief, respiratory health, digestive health, and therapeutic skin health. The company’s well-known brands include Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.